WASHINGTON, DC—There’s fresh evidence that off-label use of TAVR devices for pure native aortic valve regurgitation (NAVR) is associated with “not optimal” outcomes, although newer-generation devices, ...

PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

SAN FRANCISCO — Among patients with symptomatic, severe native aortic regurgitation at high surgical risk, the JenaValve Trilogy transcatheter heart valve system (JenaValve Technology) met its primary ...

Aortic insufficiency is a potentially severe condition that affects the heart’s ability to pump blood. There are many possible causes for this condition. Aortic insufficiency is a form of heart valve ...

Among young adults with aortic regurgitation (AR), those undergoing aortic valve replacement (AVR) before they met standard criteria were more likely to achieve good results from the surgery, a study ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve replacement (TAVR) is currently a widely used option for patients with severe ...

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...

DEAR DR. ROACH: I’ve had a leaky aortic valve for approximately six years. I recently had an echocardiogram using Doppler. The last test I received was three years ago, which came back with a reading ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

Palpation of the carotid pulse is of inestimable help in indicating which type of aortic-valve lesion predominates, and affords considerably more information than palpation at any other site. In pure ...

What is responsible for the myriad physical examination findings in patients with severe aortic regurgitation, including pulsation of multiple organs? When will the murmur of aortic valve ...

AUSTIN, Texas--(BUSINESS WIRE)--BioStable Science & Engineering, Inc. announced today the company has received CE Mark approval for the HAART 300 Aortic Annuloplasty Device, the first commercially ...